News in the Life Sciences Industry

NEW YORK, Dec. 3, 2018 /PRNewswire/ -- New drugs that harness the body's immune system to destroy cancer cells appear to increase the effectiveness of later drug therapies for non-Hodgkin and Hodgkin lymphoma patients, new research suggests. This happens, scientists say, even for repeat drug... Read more ››

WARREN, N.J., Dec. 3, 2018 /PRNewswire/ -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company, today announced findings from two clinical studies, including the Adult Epilepsy Monitoring Unit (EMU) study, showing that its investigational diazepam buccal film (DBF)... Read more ››

SAN DIEGO, Dec. 3, 2018 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage oncology therapeutics company, taking a precision medicine approach to develop drugs that target cell division (mitosis) for the treatment of leukemias, lymphomas and solid tumor cancers, today presented... Read more ››

ANCHORAGE, Alaska, Dec. 3, 2018 /PRNewswire/ -- Due to the Alaska earthquake on Friday November 30, 2018, Blood Bank of Alaska temporarily closed collections to ensure the safety of our donors. All facilities have passed required inspections and routine operations resumed December 1, 2018. ... Read more ››

NEW YORK and SAN FRANCISCO, Dec. 3, 2018 /PRNewswire/ -- Synchron Inc., a company developing minimally invasive neural interface technology, today announced data demonstrating the feasibility of minimally-invasive techniques to enable focal brain stimulation has been published in the journal... Read more ››

NEW YORK, December 3, 2018 /PRNewswire/ --

NORTH CHICAGO, Ill. and MEMPHIS, Tenn., Dec. 3, 2018 /PRNewswire/ -- AbbVie, a research-based global biopharmaceutical company, today announced a historic $50 million donation to St. Jude Children's... Read more ››

NEW YORK, Dec. 3, 2018 /PRNewswire/ -- Royalty Pharma is pleased to announce that Susannah Gray has been named Executive Vice President - Finance & Strategy, Terrance Coyne has been promoted to Chief Financial Officer, and Kristin Stafford has been promoted to Chief Accounting Officer. Ms.... Read more ››

PHILADELPHIA, Dec. 3, 2018 /PRNewswire/ -- On Tuesday, November 13, 2018, the American Medical Association's (AMA) House of Delegates voted unanimously to approve Resolution 955 "Read more ››

FAIR LAWN, N.J., Dec. 3, 2018 /PRNewswire/ -- SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative biopharmaceutical company focused on developing and bringing to market treatments for central nervous... Read more ››

LUGANO, Switzerland and SAN DIEGO, Dec. 3, 2018 /PRNewswire/ -- Helsinn Group, a Swiss pharmaceutical group focused on building quality cancer care products, and MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced... Read more ››

NEW YORK, Dec. 3, 2018 /PRNewswire/ -- In commemoration of World AIDS Day, AIDS Healthcare Foundation (AHF), the world's largest, non-profit HIV/AIDS service organization, partnered with Debbie Allen, to host "Keeping the Promise - 1,000,000... Read more ››

SAN RAFAEL, Calif., Dec. 3, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced the promotion of Amy Wireman to Group Vice President, Human Resources. Ms. Wireman's promotion to lead the Human Resources function globally is effective on January 1, 2019.

POWERS LAKE, Wis. and DURHAM, N.C., Dec. 3, 2018 /PRNewswire/ -- Pharmacy packaging and automation provider TCGRx, a portfolio company of Frazier Healthcare Partners, today announced the acquisition of Parata Systems. Established leaders in medication adherence packaging and high speed automated... Read more ››

KING OF PRUSSIA, Pa., Dec. 3, 2018 /PRNewswire/ -- Much of the nation has become fixated on the opioid epidemic that kills 115 Americans each day, and for good reason. Countless families are grappling with the devastating effects of loved ones struggling with opioid addiction. Accountability... Read more ››

NORTH CHICAGO, Ill., Dec. 3, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced results from the Phase 3 iLLUMINATE (PCYC-1130) trial, evaluating the chemotherapy-free, anti-CD20 combination of IMBRUVICA(®) (ibrutinib) plus obinutuzumab... Read more ››

SAN DIEGO, Dec. 3, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase 3 iLLUMINATE (PCYC-1130) study, which showed the combination of IMBRUVICA(®) (ibrutinib) plus obinutuzumab significantly improved progression-free survival... Read more ››

DANBURY, Conn., Dec. 3, 2018 /PRNewswire/ -- The National Organization for Rare Disorders (NORD) has announced a meeting for patients, caregivers and the medical community. The 2019 Living... Read more ››

CORALVILLE, Iowa, Dec. 3, 2018 /PRNewswire/ -- CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, announced today their partnership with POLL Medical, as the exclusive global provider of GrayDuck Stents(TM) for custom oral positioning... Read more ››

MORRISTOWN, N.J., Dec. 3, 2018 /PRNewswire/ -- Atlantic Health System's Morristown Medical Center today announced that its internationally recognized cardiac team performed the world's first transcatheter mitral valve repair (TMVr; a minimally invasive, catheter-based procedure to repair the... Read more ››